Cost evaluation of metastatic colorectal cancer treatment in the Brazilian Public Healthcare System (2015)
- Authors:
- USP affiliated authors: PEREIRA, LEONARDO RÉGIS LEIRA - FCFRP ; PERDONÁ, GLEICI DA SILVA CASTRO - FMRP ; NUNES, ALTACILIO APARECIDO - FMRP ; OLIVEIRA, HARLEY FRANCISCO DE - FMRP ; PERIA, FERNANDA MARIS - FMRP
- Unidades: FCFRP; FMRP
- DOI: 10.4172/2329-6771.1000136
- Subjects: NEOPLASIAS COLORRETAIS; QUIMIOTERAPIA; ASSISTÊNCIA À SAÚDE; SISTEMA ÚNICO DE SAÚDE
- Language: Inglês
- Imprenta:
- Publisher place: Los Angeles
- Date published: 2015
- Source:
- Título: Journal of Integrative Oncology
- ISSN: 2329-6771
- Volume/Número/Paginação/Ano: v. 4, n. 2, p. 1000136-1 - 1000136-5, 2015
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
UNGARI, Andrea Queiróz et al. Cost evaluation of metastatic colorectal cancer treatment in the Brazilian Public Healthcare System. Journal of Integrative Oncology, v. 4, n. 2, p. 1000136-1 - 1000136-5, 2015Tradução . . Disponível em: https://doi.org/10.4172/2329-6771.1000136. Acesso em: 01 mar. 2026. -
APA
Ungari, A. Q., Pereira, L. R. L., Perdoná, G. da S. C., Bettim, B. B., Nunes, A. A., Rapatoni, L., et al. (2015). Cost evaluation of metastatic colorectal cancer treatment in the Brazilian Public Healthcare System. Journal of Integrative Oncology, 4( 2), 1000136-1 - 1000136-5. doi:10.4172/2329-6771.1000136 -
NLM
Ungari AQ, Pereira LRL, Perdoná G da SC, Bettim BB, Nunes AA, Rapatoni L, Oliveira HF de, Peria FM. Cost evaluation of metastatic colorectal cancer treatment in the Brazilian Public Healthcare System [Internet]. Journal of Integrative Oncology. 2015 ; 4( 2): 1000136-1 - 1000136-5.[citado 2026 mar. 01 ] Available from: https://doi.org/10.4172/2329-6771.1000136 -
Vancouver
Ungari AQ, Pereira LRL, Perdoná G da SC, Bettim BB, Nunes AA, Rapatoni L, Oliveira HF de, Peria FM. Cost evaluation of metastatic colorectal cancer treatment in the Brazilian Public Healthcare System [Internet]. Journal of Integrative Oncology. 2015 ; 4( 2): 1000136-1 - 1000136-5.[citado 2026 mar. 01 ] Available from: https://doi.org/10.4172/2329-6771.1000136 - Cost-effectiveness analysis of XELOX versus XELOX plus bevacizumab for metastatic colorectal cancer in a public hospital school
- Intensity modulated radiotherapy (IMRT) for patients of the Brazilian unified health system (SUS): an analysis of 508 treatments two years after the technique implementation
- Capecitabine/oxaliplatin (XELOX) versus XELOX plus bevacizumab (XELOX + bev) cost-effectiveness for metastatic colorectal cancer (mCRC) in first line treatment: a Brazilian public hospital analysis
- On the comparison of risk od death according to different stages of breast cancer via the long-term exponetiated Weibull hazard model
- Influência dos fatores de risco pós prostatectomia radical na recidiva bioquímica no câncer de próstata
- Longitudinal assessment of nutritional risk in patients under chemo or radiotherapy
- Fatigue in patients with colorectal cancer treated with capecitabine and oxaliplatin
- A mechanistic breast cancer survival modelling through the axillary lymph node chain
- Sarcoma radioinduzido pós-tratamento de glioblastoma: relato de caso
- Paraneoplastic dermatomyositis associated with neuroendocrine tumor of an unknown primary site: a case report
Informações sobre o DOI: 10.4172/2329-6771.1000136 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
